Therma Bright, Inc. (THRM) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 4 Million ()

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.03

Return on Equity

-173.24%

Price to Book

3.73

Revenue and Profits:

Net Sales:

0 Million

(Quarterly Results - Apr 2025)

Net Profit:

0 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-16.67%

6 Months

-58.33%

1 Year

-68.75%

2 Years

-75.0%

3 Years

-92.65%

4 Years

-98.21%

5 Years

-91.07%

Therma Bright, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

0.59%

EBIT Growth (5y)

-202.29%

EBIT to Interest (avg)

-1.86

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.03

Sales to Capital Employed (avg)

0.04

Tax Ratio

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

3.98

EV to EBIT

-2.28

EV to EBITDA

-2.40

EV to Capital Employed

4.07

EV to Sales

4.51

PEG Ratio

Dividend Yield

ROCE (Latest)

-178.01%

ROE (Latest)

-173.24%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Jan 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Apr 2025 is 60.00% vs -25.00% in Jan 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Apr'25",
        "Jan'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.20",
          "val2": "-0.50",
          "chgp": "60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.20",
          "val2": "-0.50",
          "chgp": "60.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-115,717.60%",
          "val2": "-20,401.60%",
          "chgp": "-9,531.60%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Jul'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Jul 2024 is 0.00% vs -100.00% in Jul 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Jul 2024 is 34.21% vs 35.59% in Jul 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jul'24",
        "Jul'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.10",
          "val2": "-3.60",
          "chgp": "69.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-1.20",
          "val2": "-0.10",
          "chgp": "-1,100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-2.50",
          "val2": "-3.80",
          "chgp": "34.21%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-47,367.50%",
          "val2": "-153,919.20%",
          "chgp": "10,655.17%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Apr'25 - QoQ

Apr'25

Jan'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.20

-0.50

60.00%

Interest

0.00

Exceptional Items

0.00

0.10

-100.00%

Consolidate Net Profit

-0.20

-0.50

60.00%

Operating Profit Margin (Excl OI)

-115,717.60%

-20,401.60%

-9,531.60%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Apr 2025 is 0.00% vs 0.00% in Jan 2025

Consolidated Net Profit

QoQ Growth in quarter ended Apr 2025 is 60.00% vs -25.00% in Jan 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Jul'24

Jul'24

Jul'23

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-1.10

-3.60

69.44%

Interest

0.00

Exceptional Items

-1.20

-0.10

-1,100.00%

Consolidate Net Profit

-2.50

-3.80

34.21%

Operating Profit Margin (Excl OI)

-47,367.50%

-153,919.20%

10,655.17%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Jul 2024 is 0.00% vs -100.00% in Jul 2023

Consolidated Net Profit

YoY Growth in year ended Jul 2024 is 34.21% vs 35.59% in Jul 2023

All Annual Results

Company CV

About Therma Bright, Inc.

Therma Bright, Inc.

Pharmaceuticals & Biotechnology

Therma Bright Inc is Canada-based medical technology company, focused on providing consumers with medical devices that address their dermatological needs. The Company's technology delivers non-invasive and pain-free skin care. The Company's focus is to market its products online through social media and to re-establish relationships with North American retailers and to pursue the redesign of its existing platforms and commercialize technologies. The flag product is The Intercept CS Cold Sore Prevention System, which is consisted of an ergonomically designed hand held unit and a disposable treatment activator. The Intercept CS system provides controlled topical heat without the risk of burning the skin. The device’s controlled range of heat naturally prevents cold sore outbreaks.

Company Coordinates

Company Details

132-1173 Dundas Street East , TORONTO CA : M4M 3P1

Tel: 1 416 8672353

https://thermabright.com/

Registrar Details